Intense Pulsed Light Therapy for Dry Eye Disease: Analyzing Temporal Changes in Tear Film Stability and Ocular Surface between IPL Sessions

Cristina-Patricia Pac,José-María Sánchez-González,Carlos Rocha-de-Lossada,Nadina Mercea,Francis Ferrari,Maria Alexandra Preda,Cosmin Rosca,Mihnea Munteanu
DOI: https://doi.org/10.3390/healthcare12111119
2024-05-31
Health Care
Abstract:Background: Dry eye disease (DED), a prevalent condition with a multifactorial etiology, significantly impacts global health by causing discomfort and visual disturbance. This historical cohort study evaluates the efficacy of Intense Pulsed Light (IPL) therapy on meibomian gland dysfunction (MGD)-related evaporative DED. Methods: The study involved 110 patients (220 eyes) who underwent IPL therapy. Ethical approval was secured, and informed consent was obtained from all participants. A Tearcheck® (ESWvision, Houdan, France) device was used for ocular surface evaluation, measuring tear film stability (NIFBUT, NIABUT), tear film quantity (CTMH, TTMH), and inflammation (OSIE). The study assessed tear film and ocular surface health across multiple IPL sessions. Results: Significant improvements were observed in subjective symptoms (EFT score increased from 29.10 ± 8.87 to 35.91 ± 7.03, p < 0.01), tear film stability (NIFBUT increased from 9.37 ± 6.04 to 10.78 ± 5.83 s, p < 0.01; NIABUT increased from 11.07 ± 4.98 to 12.34 ± 4.66 s, p < 0.01), and tear film surface evaluation (TFSE score decreased from 337.78 ± 414.08 to 206.02 ± 240.44, p 0.05). Conclusions: IPL therapy is a promising treatment for DED, improving symptoms and ocular surface health. Further research is warranted to explore long-term efficacy and optimization.
health care sciences & services,health policy & services
What problem does this paper attempt to address?
### Problems the Paper Aims to Address This paper aims to systematically study the dynamic changes in tear film stability and ocular surface health in patients with Dry Eye Disease (DED) during Intense Pulsed Light (IPL) therapy, in order to evaluate the efficacy of IPL therapy in improving symptoms and underlying causes. Specifically: 1. **Background Issue**: Dry Eye Disease is a multifactorial condition affecting global health, causing discomfort and visual impairment. Evaporative dry eye is primarily caused by Meibomian Gland Dysfunction (MGD). 2. **Research Objective**: To analyze the dynamic changes in tear film stability and ocular surface health through multiple stages of IPL treatment, and to verify the effectiveness of IPL therapy in alleviating symptoms and improving ocular surface health. 3. **Treatment Method**: IPL therapy is used, which involves a series of light pulses to treat Meibomian Gland Dysfunction, thereby improving tear film stability and ocular surface health. 4. **Evaluation Metrics**: The Tearcheck® device is used to assess changes in tear film stability (NIFBUT, NIABUT), tear film quantity (CTMH, TTMH), and inflammation (OSIE). ### Main Conclusions - **Improvement in Subjective Symptoms**: EFT scores significantly increased. - **Enhanced Tear Film Stability**: NIFBUT and NIABUT values significantly increased. - **Improvement in Tear Film Surface Evaluation**: TFSE scores significantly decreased. - **No Significant Change in Tear Film Quantity**: CTMH and TTMH showed no significant changes. Overall, IPL therapy shows promising prospects for the treatment of Dry Eye Disease, but further research is needed to study its long-term efficacy and optimization strategies.